Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 3166707)

Published in Am J Epidemiol on July 18, 2011

Authors

Ping-Ping Bao1, Xiao Ou Shu, Yu-Tang Gao, Ying Zheng, Hui Cai, Sandra L Deming, Zhi-Xian Ruan, Yinghao Su, Kai Gu, Wei Lu, Wei Zheng

Author Affiliations

1: Vanderbilt Epidemiology Center, Institute of Medicine and Public Health, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN 37203-1738, USA.

Articles citing this

Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat (2014) 1.56

Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst (2014) 1.22

Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control (2012) 1.05

The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer (2015) 0.94

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev (2014) 0.92

Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer. Cancer Epidemiol Biomarkers Prev (2012) 0.92

Breast cancer incidence in Mongolia. Cancer Causes Control (2012) 0.92

Breastfeeding and maternal health outcomes: a systematic review and meta-analysis. Acta Paediatr Suppl (2015) 0.89

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer (2014) 0.89

The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China. PLoS One (2013) 0.88

Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Ann Oncol (2015) 0.87

Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility. Evol Med Public Health (2014) 0.84

A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Res (2015) 0.82

Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years. Cancer (2014) 0.82

Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries. PLoS One (2014) 0.81

Alcohol and breast cancer risk among Asian-American women in Los Angeles County. Breast Cancer Res (2012) 0.80

Associations of reproductive time events and intervals with breast cancer risk: a report from the Shanghai Breast Cancer Study. Int J Cancer (2013) 0.79

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women. Springerplus (2014) 0.78

Emerging Concepts in Breast Cancer Risk Prediction. Curr Obstet Gynecol Rep (2013) 0.78

Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses. Cancer Causes Control (2015) 0.78

Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China. PLoS One (2014) 0.76

Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. Breast Cancer Res Treat (2015) 0.76

Risk factors for breast cancer in China: similarities and differences with western populations. Arch Med Sci (2012) 0.76

Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. Eur J Cancer (2016) 0.75

BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis. J Epidemiol (2016) 0.75

Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study. Am J Epidemiol (2016) 0.75

Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Breast Cancer Res (2017) 0.75

Traditional Breast Cancer Risk Factors in Filipina Americans Compared with Chinese and Japanese Americans in Los Angeles County. Cancer Epidemiol Biomarkers Prev (2016) 0.75

Articles cited by this

Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev (2004) 5.32

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst (2005) 4.25

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol (2000) 2.93

History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82

Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer (2000) 2.62

Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev (1995) 2.50

Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol (2005) 2.49

Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol (2009) 2.14

The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res (2002) 2.07

Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat (2002) 2.04

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis. Int J Cancer (2009) 1.88

Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2006) 1.66

Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev (2003) 1.63

Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer (2004) 1.56

Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev (2008) 1.55

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer (2001) 1.52

Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol (2007) 1.50

Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50

Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res (2006) 1.50

Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat (2009) 1.49

Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study. Int J Cancer (2006) 1.40

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol (2002) 1.39

Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring) (2009) 1.22

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol (2008) 1.17

Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol (2006) 1.05

Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2006) 1.04

Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci (2009) 1.00

Breast tumours following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer (2007) 0.89

Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev (2009) 0.87

[Characterization of hormone receptor status in 5758 Chinese females with breast cancer]. Zhonghua Zhong Liu Za Zhi (2009) 0.86

Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol (2000) 0.85

Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women. Breast (2008) 0.83

Fat distribution, androgens, and metabolism in nonobese women. Am J Clin Nutr (1989) 0.83

Articles by these authors

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01

Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A (2006) 9.92

Ge/Si nanowire heterostructures as high-performance field-effect transistors. Nature (2006) 8.50

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

A highly annotated whole-genome sequence of a Korean individual. Nature (2009) 6.91

Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89

The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol (2005) 6.44

Nanoscale memristor device as synapse in neuromorphic systems. Nano Lett (2010) 6.28

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron (2010) 4.76

Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol (2007) 4.63

High-throughput screening assays for the identification of chemical probes. Nat Chem Biol (2007) 4.50

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Improved synthesis of graphene oxide. ACS Nano (2010) 4.32

A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res (2011) 4.22

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67

Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell (2003) 3.66

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res (2010) 3.16

Soy food intake and breast cancer survival. JAMA (2009) 3.16

The landscape of recombination in African Americans. Nature (2011) 3.06

Observation of conducting filament growth in nanoscale resistive memories. Nat Commun (2012) 3.02

Glycopeptide and lipoglycopeptide antibiotics. Chem Rev (2005) 3.01

Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 2.97

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol (2011) 2.85

Epidermal stem cells arise from the hair follicle after wounding. FASEB J (2007) 2.81

Abdominal adiposity and mortality in Chinese women. Arch Intern Med (2007) 2.75

Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol (2004) 2.74

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol (2004) 2.73

Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A (2005) 2.72

Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70

Nitrogen fixation island and rhizosphere competence traits in the genome of root-associated Pseudomonas stutzeri A1501. Proc Natl Acad Sci U S A (2008) 2.70

Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69

Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine. J Infect Dis (2003) 2.68

Identification of new genetic risk variants for type 2 diabetes. PLoS Genet (2010) 2.62

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61

Manganese toxicity upon overexposure. NMR Biomed (2004) 2.61

LTP requires a reserve pool of glutamate receptors independent of subunit type. Nature (2012) 2.59

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Focused ultrasound to expel calculi from the kidney. J Urol (2011) 2.55

Novel breathing motion model for radiotherapy. Int J Radiat Oncol Biol Phys (2005) 2.51

Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol (2010) 2.48

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol (2011) 2.42

Energy doubling of 42 GeV electrons in a metre-scale plasma wakefield accelerator. Nature (2007) 2.36

Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr (2007) 2.35

In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34

Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am J Epidemiol (2013) 2.34

Chemical calcium indicators. Methods (2008) 2.33

Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med (2007) 2.31